Using the Power of Technology & Innovative Science to Advance Patient Care

Multimedia with summary

There have been great strides made recently in treating the most difficult and debilitating health conditions people face. Yet, there is still much work to be done if we are going to find truly effective therapies for these conditions. At Pfizer, we work to make our drug development process more efficient by collaborating with unique partners and exploring new pathways that harness technology and emerging science.

Providing Patients with Global Health Resources


Pfizer believes that all individuals deserve access to quality health care and the opportunity to lead healthy lives. We combine creative commercial strategies with philanthropic approaches to create a sustainable and meaningful impact on global health. In 2016, we made significant strides in advancing this goal, including:

Creating a Blueprint for Eliminating Trachoma


After more than six decades of fighting the spread of trachoma in Morocco, on November 14, 2016, the World Health Organization (WHO) acknowledged that the Moroccan government eliminated the world’s leading infectious cause of blindness as a public health problem.

Transforming Delivery of High Quality Products

Multimedia with summary

At Pfizer, we are developing innovative manufacturing techniques that better meet today’s patient needs. 

In recent years, Pfizer has made dramatic advances in our manufacturing and supply chain. In 2016, we enabled even more efficient product delivery by applying the latest technologies and innovative partnerships to our manufacturing processes and supply chain. These advances include:

· Creating a first-of-its-kind manufacturing system that will give Pfizer increased flexibility and speed of production

Pfizer Launches 2016 Annual Review Highlighting Commitment to UN SDGs


Today, Pfizer launched its 2016 Annual Review, which provides an in-depth look at all of the ways Pfizer is accelerating patient impact and fulfilling its purpose: to make innovative medicines and vaccines that significantly improve people’s lives.

Pfizer Launches 2016 Annual Review


Today, Pfizer launched its 2016 Annual Review, which provides an in-depth look at how the company is working to accelerate patient impact. The report provides an overview of the company’s financial, social and environmental performance throughout last year.

Pfizer, Partners Will Discuss “How to End a Plague” during SXSW Panel


“In your pocket, you have a tool that we have employed to map the world’s leading infectious cause of blindness.”
– Dr. Paul Emerson, Director of the International Trachoma Initiative at The Task Force for Global Health.

Pfizer Foundation Grantee Sevamob Uses Entrepreneurial Approach to Provide Low-cost Care in India and South Africa

Multimedia with summary

Shelley Saxena is the Founder and Chief Executive Officer of Sevamob, which operates 18 mobile clinics in India and South Africa that provide care for more than 20,000 people each month. Shelley is using his entrepreneurial background to redefine expectations about the cost of quality healthcare for low-income patients. Sevamob’s clinics provide critical access to primary and preventive care using a subscription-based model. 

Pfizer Foundation Grantee Clinicas del Azúcar Approaches Diabetes Care in Mexico “From a Different Perspective”

Multimedia with summary

Miguel Garza is the Chief Financial Officer and Director of New Business Development for Clínicas del Azúcar. Based in Monterrey, Mexico, the organization’s mission is to provide high-quality low-cost care to prevent and treat diabetes. Clínicas del Azúcar’s leaders use their background in business to apply entrepreneurial skills to improve the health of people who would otherwise not have access to specialized care.

Pfizer Foundation Grantee Afya Research Africa Seeks to Improve “Health and Wealth” of Underserved Communities

Multimedia with summary

Sam Gwer is the Executive Director of Afya Research Africa, which operates a network of clinics in Kenya that aim to improve primary care in underserved, rural areas. The organization currently operates 11 clinics in farming and fishing communities, serving 15,000 people.

“We have really empowered communities, and they can see value and the need to participate,” Sam explains in this video. “This is empowering because then with this intervention, we’re able to make an impact on health and wealth.”


Subscribe to Pfizer